Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
2.830
+0.050 (1.80%)
At close: Aug 13, 2025, 4:00 PM
2.840
+0.010 (0.35%)
Pre-market: Aug 14, 2025, 5:36 AM EDT

Firefly Neuroscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.430.110.5-0.03
Revenue Growth (YoY)
568.75%-78.31%---
Gross Profit
0.40.110.5-0.03
Selling, General & Admin
8.977.332.842.071.76
Research & Development
1.961.950.741.32.93
Operating Expenses
10.939.293.583.374.69
Operating Income
-10.53-9.18-3.08-3.37-4.65
Interest Expense
-0.2-0.07-0.02-0.44-0.14
Currency Exchange Gain (Loss)
00.010.04-0.13-
Other Non Operating Income (Expenses)
-9.9-0.330.460.01-0
EBT Excluding Unusual Items
-20.59-9.57-2.6-3.93-4.79
Gain (Loss) on Sale of Investments
----0.55
Gain (Loss) on Sale of Assets
-0.01-0.01-0.170.31
Asset Writedown
-0.87-0.87--0.08-
Other Unusual Items
-1.35---0.06-0.45
Pretax Income
-22.83-10.46-2.6-3.9-4.38
Income Tax Expense
0.0100--
Net Income
-22.84-10.46-2.6-3.9-4.38
Net Income to Common
-22.84-10.46-2.6-3.9-4.38
Shares Outstanding (Basic)
10731-
Shares Outstanding (Diluted)
10731-
Shares Change (YoY)
-80.76%102.48%134.29%--
EPS (Basic)
-2.38-1.60-0.81-2.83-
EPS (Diluted)
-2.83-1.60-0.81-2.83-
Free Cash Flow
-8.74-6.3-2.17-2.89-3.82
Free Cash Flow Per Share
-0.91-0.96-0.67-2.10-
Gross Margin
94.16%100.00%100.00%-100.00%
Operating Margin
-2460.05%-8500.00%-618.07%--14543.75%
Profit Margin
-5335.75%-9685.18%-522.69%--13690.63%
Free Cash Flow Margin
-2042.29%-5836.11%-436.14%--11937.50%
EBITDA
-10.46-9.17-3.06-3.35-4.23
D&A For EBITDA
0.070.010.010.010.43
EBIT
-10.53-9.18-3.08-3.37-4.65
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q